From the publishers of JADPRO

Acute Lymphoblastic Leukemia Resource Center

Advertisement

Journal for Immunotherapy of Cancer

CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy

Leukemia

T-cell acute lymphoblastic leukemia: Subtype prevalence, clinical outcome, and emerging targeted treatments

Oncology and Therapy

Promising drugs targeting specific mechanisms of deregulation in T cell lineage acute lymphoblastic leukemia

Leukemia Research

Incidence and risk factors of venous thromboembolism in patients with acute Leukemia: A systematic review and meta-analysis

Haematologica

Acute therapy-related toxicities in pediatric acute lymphoblastic leukemia

Journal Of Pediatric Health Care

Changes in symptom clusters over the course of chemotherapy in children with acute lymphoblastic leukemia: A longitudinal survey

American Journal of Clinical Oncology

Impact of minimal residual diseases status and depth of response on survival outcomes in blinatumomab-treated acute lymphoblastic leukemia: A systematic review and meta-analysis

Blood

Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: The GIMEMA LAL2317 phase 2 study

American Journal of Clinical Oncology

A meta-analysis on effects of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia

European Journal of Pediatrics

Quality of life trajectories in children aged 2-4 years with acute lymphoblastic leukemia

BMC Health Services Research

Exploring the financial burden of pediatric bone marrow transplantation: A cross-sectional study from the caregiver's viewpoint

Pharmacotherapy

Evaluation of methotrexate pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia

Psycho-Oncology

Systematic review of pain assessment measures used in pediatric acute lymphoblastic leukemia

Ecancer

Utility of glass slide morphology (GSM) and whole slide image (WSI) in the diagnosis of acute leukemia (AL) by types

Expert Review of Hematology

Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: A systematic literature review

Blood

Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: The DELPHINUS study

A Rare Instance of Testicular Relapse of T-Cell Acute Lymphoblastic Leukemia